Detection of cholinesterase inhibition with microfluidic devices and systems thereof

US11680946B1 · US · B1

Patent metadata
FieldValue
Publication numberUS-11680946-B1
Application numberUS-202117143363-A
CountryUS
Kind codeB1
Filing dateJan 7, 2021
Priority dateJan 16, 2020
Publication dateJun 20, 2023
Grant dateJun 20, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to methods of conducting cholinesterase inhibition assays. In one instance, the assays can be configured to determine the presence of inactivated and activated cholinesterases. Also described herein are microfluidic devices and systems for conducting such assays.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of conducting a cholinesterase inhibition assay, the method comprising: generating a plurality of beads in a fluid sample, wherein each bead of the plurality of beads comprises: (i) a first population of a plurality of complexes comprising a capture agent and an activated cholinesterase and (ii) a second population of a plurality of complexes comprising a capture agent and an inactivated cholinesterase, such that each bead comprises both inactivated cholinesterase and activated cholinesterase; transporting the plurality of beads including the complexes through a density medium in a detection chamber, wherein the density medium is characterized by a density that is less than a density of the plurality of beads and more than a density of the fluid sample, and wherein the transporting occurs, at least in part, by sedimentation; and detecting a presence or an absence of a first signal from the activated cholinesterase in the detection chamber, wherein the first signal arises from reacting the activated cholinesterase with a first probe and an optional second probe; wherein an amount of capture agent disposed on a surface of each bead comprises a surface concentration configured to be saturated upon mixing with the fluid sample, thereby directly providing percent inhibition of cholinesterase that is independent of baseline, pre-exposure activity. 2. The method of claim 1 , further comprising, before or after the transporting step: binding a detection antibody to one or more of the plurality of complexes on the plurality of beads, thereby providing one or more detectable complexes. 3. The method of claim 2 , further comprising, after said binding: detecting a second signal from the detection antibody of the one or more detectable complexes bound to the plurality of beads. 4. The method of claim 1 , wherein the activated or inactivated cholinesterase is an acetylcholinesterase or a butyrylcholinesterase. 5. The method of claim 1 , wherein the inactivated cholinesterase is an acetylcholinesterase or a butyrylcholinesterase bound to an organophosphorous agent. 6. The method of claim 1 , wherein the capture agent binds to both the activated cholinesterase and the inactivated cholinesterase. 7. The method of claim 2 , wherein the detection antibody binds to both the activated cholinesterase and the inactivated cholinesterase. 8. The method of claim 1 , wherein the first probe and/or the second probe, if present, comprises a compound of formula (I), (Ia), (IV), (VI), (VIa), or (VIII), or a salt thereof. 9. The method of claim 1 , wherein the detection chamber is disposed within a substrate and the transporting step comprises spinning the substrate. 10. The method of claim 1 , wherein the fluid sample comprises a nasal fluid or a cerebrospinal fluid.

Assignees

Inventors

Classifications

  • Disc shape · CPC title

  • specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules · CPC title

  • Absorbents; Gels to retain a fluid · CPC title

  • G01N33/573Primary

    for enzymes or isoenzymes · CPC title

  • Integrated biosensor, microarrays · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11680946B1 cover?
The present invention relates to methods of conducting cholinesterase inhibition assays. In one instance, the assays can be configured to determine the presence of inactivated and activated cholinesterases. Also described herein are microfluidic devices and systems for conducting such assays.
Who is the assignee on this patent?
Nat Tech & Eng Solutions Sandia Llc
What technology area does this patent fall under?
Primary CPC classification G01N33/573. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).